Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.42

+1.50 (2.50%)

as of Sep 3, 2026, 8:00:00 pm Market Open.

1632 watching

Investor Insights

Sep 3, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mixture of opinions from analysts following its recent quarterly report, which showcased positive developments despite facing challenges such as a new tax on its products for mainland Chinese residents. The company is noted for its strong presence in Asia and steady growth in its wealth management segment, which remains a highlight in its long-term strategy. However, some experts express caution, labeling MFC as a bit overvalued relative to its earnings growth potential, currently trading over 2x book value. The financial landscape for insurers in Canada appears competitive, with both MFC and its peers like TD exhibiting relatively robust performance, yet the consensus leans toward a cautious approach due to market conditions. Overall, while MFC benefits from high dividends and solid asset management, uncertainties related to its exposure to market fluctuations warrant careful monitoring for potential entry points.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF

HOLD

Had a big blip down in Feb/March and it is really going back to be coming more of a steady state industry. Stock was whipsawed because they came close to violating some ratios on some of their products. Ratios are getting back in line.

SELL

Great company with great potential overseas. Because of the stock market rally they have done well. He does not think this rally is sustainable. If you own, consider taking some profits.

DON'T BUY

Upside. Insurance field is badly beaten up. Changes are definitely for the better. Likes the dividend – is safe.

DON'T BUY

Outlook is difficult. Still have issues to contend with. Balance sheet issues. Possible home run but there are dangers.

SELL

The worst is over. Doubled in the period of 2 months. Still a good long-term hold, but he is lightening his load.

SELL

Did own. Model price of 21.95. It followed the market. Slow and steady. Doesn’t know if it will qualify at the end of the month for them. Would trade financials rather than hold them.

COMMENT

During next two weeks as we digest earnings we will know more. Volume has picked up. Should review in two weeks what’s going on.

BUY ON WEAKNESS

Was oversold when it was in the $10 range. Full of pessimism. Rebound takes it back into line. Thinks it will trade sideways and you could pick it up on weakness. Don’t wait for it to hit $10. Could go back to $15-$17. Favourite play in the insurance space, but Sunlife might be a better play short term.

Wealthica Track your Stocks in your Watch List

COMMENT

Should not have to raise equity in the short term. They’re good for now. A good part of their valuation is based on their equity portfolio. If Equity markets fall back, shares will fall off.

DON'T BUY

Took profits after the 100% run up. Prefers risk/return of banks over lifecos. Viewed right now as a play on the market. In the short term the run-up might have been a little overdone.

BUY

Insurance companies came down with banks but to a degree have higher risks attached to them such as dividend and bad news down the line. Sell equity type products that expose them to more risks. This one is well managed and has good products. Great far Eastern exposure. If you are a little more risk inclined, this is probably not a bad investment here.

HOLD

(Market Call Minute.) If there is another down leg in the financial sector this will get hit again.

TOP PICK

Great bounce from its March 19 low but tremendous volatility over the last year. Problem has the requirement to increase reserves due to commitments on guaranteed policies and annuities. However, those don't start coming due until 5 to 7 years from now. Basic business is still very strong and produces a tremendous amount of cash flow.

WAIT

Looking at this very closely. Likes fundamentals of their insurance business including geographic diversity and successful acquisitions. The problem is exposure to equity markets in terms of segregated products. Still vulnerable. Would wait until you are more confident that the turn has happened.

BUY

The negative for them was that if the market continued to fall, they had obligations that would have hurt them. With the market recovering, this is one you could look at.

Showing 1,636 to 1,650 of 2,284 entries

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Dan Rohinton

iA Global Asset Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)